Search

Your search keyword '"Coindre, Jean Michél"' showing total 74 results

Search Constraints

Start Over You searched for: Author "Coindre, Jean Michél" Remove constraint Author: "Coindre, Jean Michél" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
74 results on '"Coindre, Jean Michél"'

Search Results

1. Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

2. Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy

3. Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations

5. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

6. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation

7. Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas

10. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

11. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions

14. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

17. Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group

19. Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

20. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

22. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification

45. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone

Catalog

Books, media, physical & digital resources